欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6039/001
药品名称Levetiracetam Noridem 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
活性成分
    • Levetiracetam 100.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Noridem Enterprises Ltd. Evagorou & Makariou, Mitsi Building 3, Suite 115 1065 NICOSIA Cyprus
参考成员国 - 产品名称Germany (DE)
Levetiracetam Noridem 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Belgium (BE)
      Levetiracetam Noridem 100 mg / ml Solution à diluer pour perfusion
    • Denmark (DK)
      Levetiracetam Noridem
    • Ireland (IE)
    • France (FR)
    • Greece (GR)
    • Cyprus (CY)
      Levetiracetam Noriderm 100mg/ml concentrate solution for infusion
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
许可日期2020/09/01
最近更新日期2025/02/27
药物ATC编码
    • N03AX14 levetiracetam
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase